Table 1.
Epidemiological data from 293 MMF patients registered in Henri Mondor hospital database.
| Age (years) Mean; median | 52.7; 53.5 |
| Sex ratio (M/F) | 88/205 |
| Mean number of aluminum-containing vaccines as indicated in vaccination booklets | 5; range: 1–12 (data available in 183/293) |
| Mean persistence time of aluminum (months) | 70 |
| Mean delay between onset of symptoms and biopsy (months) | 66.7 |
| Symptoms | |
| Myalgias | 254/278 (91%) |
| Fatigue | 248/280 (89%) |
| Cognitive complaint | 107/133 (80%) |
| Results of neuropsychological testing | N = 76 |
| Cortico-subcortical profile | 64/76 (84.2%) |
| Isolated callosal deconnexion | 4/76 (5.3%) |
| Isolated dysexecutive syndrome | 3/76 (3.9%) |
| Normal | 5/76 (6.6%) |
| Abnormal evoked potentials | 7/22 (31.8%) |
| Myopathic EMG | 15/43 (34.9%) |
| Elevated CK serum levels | 12/48 (25%) |